Cargando…
Anti-Tumor Effects of Carrimycin and Monomeric Isovalerylspiramycin I on Hepatocellular Carcinoma in Vitro and in Vivo
Hepatocellular carcinoma results in a high risk of second primary malignancies and has prominent morbidity and mortality. There is a lack of effective treatment and prognosis is poor. Therefore, effective drugs need to be discovered. Carrimycin is a 16-member macrolide antibiotic with anticancer act...
Autores principales: | Jin, Yong, Zuo, Hong Xiang, Li, Ming Yue, Zhang, Zhi Hong, Xing, Yue, Wang, Jing Ying, Ma, Juan, Li, Gao, Piao, Hongxin, Gu, Puqing, Jin, Xuejun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662527/ https://www.ncbi.nlm.nih.gov/pubmed/34899336 http://dx.doi.org/10.3389/fphar.2021.774231 |
Ejemplares similares
-
Anti-inflammatory effect and antihepatoma mechanism of carrimycin
por: Li, Xiu-Yan, et al.
Publicado: (2023) -
Targeting selenoprotein H in the nucleolus suppresses tumors and metastases by Isovalerylspiramycin I
por: Cui, Jing, et al.
Publicado: (2022) -
Anti-tumor effect of carrimycin on oral squamous cell carcinoma cells in vitro and in vivo
por: Liang, Si-yuan, et al.
Publicado: (2021) -
A Case of Multidrug-Resistant Klebsiella pneumoniae Treated with Carrimycin
por: Zhu, Wenjun, et al.
Publicado: (2023) -
Isovalerylspiramycin I suppresses non-small cell lung carcinoma growth through ROS-mediated inhibition of PI3K/AKT signaling pathway
por: Liu, Zeyu, et al.
Publicado: (2022)